Multicentric Castleman disease of hyaline vascular variant presenting with unusual systemic manifestations: a case report
Open Access
- 14 May 2017
- journal article
- case report
- Published by Springer Nature in Journal of Medical Case Reports
- Vol. 11 (1) , 1-4
Abstract
Castleman disease is a rare lymphoproliferative disorder presenting with localized or disseminated lymphadenopathy and systemic manifestations. It can be categorized in numerous ways, such as unicentric versus multicentric, histopathological variants (hyaline-vascular, plasma cell, and mixed), or subtypes based on causative viral infections (human immunodeficiency virus, human herpesvirus-8, or Kaposi sarcoma herpesvirus). Presentation ranges from asymptomatic to symptoms involving multiple organs. Even though the exact mechanism of pathogenesis is unknown, treatment is directed toward possible etiologies such as interleukin-6, cluster of differentiation 20, and viral agents. A 36-year-old Sri Lankan woman presented with generalized body swelling and foamy urine of 2 weeks’ duration. Examination revealed pallor; generalized edema; axillary, cervical, and inguinal lymphadenopathy; hypertension; and hepatomegaly. Investigations showed bicytopenia, nephrotic range proteinuria with hypoalbuminemia, hypogammaglobulinemia, and features of hyaline-vascular type Castleman disease in a lymph node biopsy. She was managed with rituximab and had good clinical improvement. Castleman disease has a broad spectrum of clinical manifestations, disease pathogeneses, and associations and/or complications. Medical professionals need to be familiar with this spectrum because timely diagnosis and aggressive targeted therapy are the cornerstones of managing these patients.Keywords
Funding Information
- not applicable
This publication has 15 references indexed in Scilit:
- Diagnosis and Management of Castleman DiseaseCancer Control, 2014
- Castleman Disease: The Great MimicRadioGraphics, 2011
- Castleman DiseaseAdvances in Anatomic Pathology, 2009
- Castleman Disease of the Hyaline-Vascular Type Confined to the KidneyAmerican Journal of Clinical Pathology, 2007
- The aetiology and management of Castleman disease at 50 years: translating pathophysiology to patient careBritish Journal of Haematology, 2005
- A case of multicentric Castleman's disease associated with advanced systemic amyloidosis treated with chemotherapy and anti-CD20 monoclonal antibodyAnnals of Hematology, 2003
- Castleman's disease with nephrotic syndrome, amyloidosis and autoimmune manifestationsNephrology Dialysis Transplantation, 2001
- Castleman’s Disease and Mesangial Proliferative Glomerulonephritis: The Role of Interleukin-6Nephron, 1998
- Sensitivity of Kaposi's sarcoma-associated herpesvirus replication to antiviral drugs. Implications for potential therapy.Journal of Clinical Investigation, 1997
- Hyaline‐vascular and plasma‐cell types of giant lymph node hyperplasia of the mediastinum and other locationsCancer, 1972